AD HOC INFORMATION
December 09, 2006
Symrise specifies offer price and offering volume
(Holzminden/Frankfurt) Together with the selling shareholders and the Joint Bookrunners, Symrise AG set the offer price today for the 70,461,181 offered shares of Symrise AG, plus an additional up to 10,569,177 shares to cover a possible over-allotment, at EUR 17.25 per share.
Thus, the offer price is in the upper part of the price range from EUR 15.75 to EUR 17.75 per share. 37,800,000 shares are from a capital increase and 32,661,181 shares from the holdings of the selling shareholders. Including the over-allotment, a total of 81,030,358 shares have been allocated. The offering volume (including the over-allotment) will therefore amount to approximately EUR 1.4 billion. The gross issue proceeds to Symrise AG will be approximately EUR 652 million.
Approximately 15% of the offered shares (without the over-allotment) have been placed with retail investors.
Trading will begin on the official market (Prime Standard) of the Frankfurt Stock Exchange on December 11, 2006.
Additional information:
ISIN: DE000SYM9999
Security Identification Number: SYM999
Listing: Official Market / Prime Standard; Frankfurt Stock Exchange
Registered office of the company: Germany
Symrise AG
Alexander Kleinke
Investor Relations
Mühlenfeldstrasse 1
D - 37603 Holzminden
E-mail: alexander.kleinke@symrise.com
Tel.: ++49 5531 90 2130
About Symrise:
Symrise AG is one of the world's leading suppliers of fragrances and flavourings and has roots that go back to 1874. Our products are essential features of everyday life today. They are used by perfume, cosmetics and food manufacturers. We focus on the development of innovative trend and lifestyle products with a specific additional benefit for the consumer. They include flavourings in which advantage is taken of modern technologies to reduce the sugar, salt and fat content of food considerably. Thanks to the use of selected active substances from Symrise, cosmetic products can be manufactured without any preservatives in future.
Press inquiries:
Kirchhoff Consult AG
Division Manager
Dr Kay Baden
Tel. +49 40 60 91 86 50
Disclaimer
These materials are not an offer of securities for sale in the United States. Any securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended, (the Securities Act), and may not be offered or sold in the United States absent registration or pursuant to an available exemption from registration under the Securities Act. Any public offering of securities of Symrise AG to be made in the United States would have to be made by means of a prospectus that could be obtained from Symrise AG and that would contain detailed information about the company and management, as well as financial statements. Neither Symrise AG nor EQT III fund intends to register any securities referred to herein in the United States.
